Literature DB >> 27942473

Post-operative pediatric cerebellar mutism syndrome and its association with hypertrophic olivary degeneration.

Shivaram Avula1, Michaela Spiteri2, Ram Kumar, Emma Lewis2, Srikrishna Harave1, David Windridge2, Chan Ong1, Barry Pizer.   

Abstract

BACKGROUND: The dentato-thalamo-cortical (DTC) pathway is recognized as the anatomical substrate for postoperative pediatric cerebellar mutism (POPCMS), a well-recognized complication affecting up to 31% of children undergoing posterior fossa brain tumour resection. The proximal structures of the DTC pathway also form a segment of the Guillain and Mollaret triangle, a neural network which when disrupted causes hypertrophic olivary degeneration (HOD) of the inferior olivary nucleus (ION). We hypothesize that there is an association between the occurrence of POPCMS and HOD and aim to evaluate this on MR imaging using qualitative and quantitative analysis of the ION in children with and without POPCMS.
METHODS: In this retrospective study we qualitatively analysed the follow up MR imaging in 48 children who underwent posterior fossa tumour resection for presence of HOD. Quantitative analysis of the ION was possible in 28 children and was performed using semi-automated segmentation followed by feature extraction and feature selection techniques and relevance of the features to POPCMS were evaluated. The diagnosis of POPCMS was made independently based on clinical and nursing assessment notes.
RESULTS: There was significant association between POPCMS and bilateral HOD (P=0.002) but not unilateral HOD. Quantitative analysis showed that hyperintensity in the left ION was the most relevant feature in children with POPCMS.
CONCLUSIONS: Bilateral HOD can serve as a reliable radiological indicator in establishing the diagnosis of POPCMS particularly in equivocal cases. The strong association of signal change due to HOD in the left ION suggests that injury to the right proximal efferent cerebellar pathway plays an important role in the causation of POPCMS.

Entities:  

Keywords:  Cerebellar mutism syndrome (CMS); hypertrophic olivary degeneration; posterior fossa syndrome (PFS); postoperative pediatric cerebellar mutism syndrome

Year:  2016        PMID: 27942473      PMCID: PMC5130563          DOI: 10.21037/qims.2016.10.11

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  26 in total

1.  Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood.

Authors:  Joelene F Huber; Kim Bradley; Brenda J Spiegler; Maureen Dennis
Journal:  Childs Nerv Syst       Date:  2005-09-10       Impact factor: 1.475

Review 2.  Intra-operative 3-T MRI for paediatric brain tumours: challenges and perspectives.

Authors:  L J Abernethy; S Avula; G M Hughes; E J Wright; C L Mallucci
Journal:  Pediatr Radiol       Date:  2012-02

3.  Olivary enlargement: chronological and morphometric analyses.

Authors:  N Goto; M Kaneko
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

4.  Impaired non-motor learning and error detection associated with cerebellar damage. A single case study.

Authors:  J A Fiez; S E Petersen; M K Cheney; M E Raichle
Journal:  Brain       Date:  1992-02       Impact factor: 13.501

5.  The syndrome of 'cerebellar' mutism and subsequent dysarthria.

Authors:  H R van Dongen; C E Catsman-Berrevoets; M van Mourik
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

6.  Mutism after posterior fossa tumour resection in children: incomplete recovery on long-term follow-up.

Authors:  Paul Steinbok; D Douglas Cochrane; Richard Perrin; Angela Price
Journal:  Pediatr Neurosurg       Date:  2003-10       Impact factor: 1.162

7.  Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome.

Authors:  Jeffrey G Ojemann; Savannah C Partridge; Andrew V Poliakov; Toba N Niazi; Dennis W Shaw; Gisele E Ishak; Amy Lee; Samuel R Browd; J Russell Geyer; Richard G Ellenbogen
Journal:  Childs Nerv Syst       Date:  2013-07-02       Impact factor: 1.475

Review 8.  The pathophysiology of oral pharyngeal apraxia and mutism following posterior fossa tumor resection in children.

Authors:  A T Dailey; G M McKhann; M S Berger
Journal:  J Neurosurg       Date:  1995-09       Impact factor: 5.115

9.  Clinical and neuroanatomical predictors of cerebellar mutism syndrome.

Authors:  Nicole Law; Mark Greenberg; Eric Bouffet; Michael D Taylor; Suzanne Laughlin; Douglas Strother; Christopher Fryer; Dina McConnell; Juliette Hukin; Caelyn Kaise; Frank Wang; Donald J Mabbott
Journal:  Neuro Oncol       Date:  2012-09-05       Impact factor: 12.300

10.  Identifying quantitative imaging features of posterior fossa syndrome in longitudinal MRI.

Authors:  Michaela Spiteri; David Windridge; Shivaram Avula; Ram Kumar; Emma Lewis
Journal:  J Med Imaging (Bellingham)       Date:  2015-10-23
View more
  11 in total

Review 1.  Hypertrophic olivary degeneration in children after posterior fossa surgery. An underdiagnosed condition.

Authors:  Matheus Fernando Manzolli Ballestero; Dinark Conceição Viana; Thiago Lyrio Teixeira; Marcelo Volpon Santos; Ricardo Santos de Oliveira
Journal:  Childs Nerv Syst       Date:  2017-12-26       Impact factor: 1.475

2.  Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous and consecutive series of 136 patients.

Authors:  Camilla de Laurentis; Paola M F Cristaldi; Paola Rebora; Maria Grazia Valsecchi; Veronica Biassoni; Elisabetta Schiavello; Giorgio G Carrabba; Andrea Trezza; Francesco DiMeco; Paolo Ferroli; Giuseppe Cinalli; Marco Locatelli; Marco Cenzato; Giuseppe Talamonti; Marco M Fontanella; Giannatonio Spena; Roberto Stefini; Claudio Bernucci; Silvio Bellocchi; Davide Locatelli; Maura Massimino; Carlo Giussani
Journal:  J Neurooncol       Date:  2022-06-29       Impact factor: 4.506

3.  Hypertrophic olivary degeneration: a description of four cases of and a literature analysis.

Authors:  Qian Gao; Zhenfei Li; Cong Guo; Shi Wang; Xueyu Liu; Qiao Wei; Xuan Zhou; Liping Chen
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 4.  Modafinil in the rehabilitation of a patient with post-surgical posterior fossa syndrome: a lesson to be learned?

Authors:  Emanuela Molinari; Maria Oto; Ashita Waterston; Natasha Fullerton
Journal:  Cerebellum Ataxias       Date:  2019-08-15

Review 5.  Functional Outcomes of Cerebellar Malformations.

Authors:  Jason S Gill; Roy V Sillitoe
Journal:  Front Cell Neurosci       Date:  2019-10-04       Impact factor: 5.505

6.  Fully-Automated Identification of Imaging Biomarkers for Post-Operative Cerebellar Mutism Syndrome Using Longitudinal Paediatric MRI.

Authors:  Michaela Spiteri; Jean-Yves Guillemaut; David Windridge; Shivaram Avula; Ram Kumar; Emma Lewis
Journal:  Neuroinformatics       Date:  2020-01

7.  Functional tracts of the cerebellum-essentials for the neurosurgeon.

Authors:  Thomas Beez; Christopher Munoz-Bendix; Hans-Jakob Steiger; Daniel Hänggi
Journal:  Neurosurg Rev       Date:  2020-02-13       Impact factor: 3.042

8.  Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study.

Authors:  Eike Steidl; Maximilian Rauch; Elke Hattingen; Stella Breuer; Jan Rüdiger Schüre; Marike Grapengeter; Manoj Shrestha; Christian Foerch; Martin A Schaller-Paule
Journal:  Front Neurol       Date:  2022-08-03       Impact factor: 4.086

Review 9.  Pediatric Central Nervous System Tumors: State-of-the-Art and Debated Aspects.

Authors:  Mitchell T Foster; Lalgudi Srinivasan Harishchandra; Conor Mallucci
Journal:  Front Pediatr       Date:  2018-11-01       Impact factor: 3.418

Review 10.  Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors.

Authors:  Peter L Stavinoha; Martha A Askins; Stephanie K Powell; Natasha Pillay Smiley; Rhonda S Robert
Journal:  Bioengineering (Basel)       Date:  2018-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.